Erika Jones serves as Executive at Black Diamond Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Erika Jones has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 21, 2026 involved receiving (via award) 200,000 shares valued at $0.
Erika Jones currently holds 200,000 shares of Black Diamond Therapeutics, Inc. (BDTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Erika Jones has been a net neutral trader of BDTX stock. They have purchased $0 and sold $0 worth of shares.
Erika Jones's most recent insider trade was on Jan 21, 2026, when they sold 200,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 15, 2022 | BDTX | $0 | Award | 5,075 | $N/A | Discretionary |